How can we regulate medicines better?

[1] Angell M., 2004, TRUTH DRUG CO THEY D

[2] Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures [J]. BRITISH JOURNAL OF CANCER, 2005, 93 (05) : 504 - 509

[3] Chalmers L, 2004, NEW SCI, V181, P19

[4] Postmarketing surveillance - Lack of vigilance, lack of trust [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21): : 2647 - 2650

[5] How can research ethics committees protect patients better? [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7400): : 1199 - 1201

[6] Adjusting Europe's drug regulation to public health needs [J]. LANCET, 2001, 358 (9275) : 64 - 67

[7] Godlee F, 2006, BMJ-BRIT MED J, V2006, P333

[8] COX-2 inhibitors, other NSAIDs, and cardiovascular risk - The seduction of common sense [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (13): : 1653 - 1656

[9] Open access to industry's clinically relevant data - Urgently needed, but when will we get it, and in what form? [J]. BRITISH MEDICAL JOURNAL, 2004, 329 (7457): : 64 - 65

[10] Association between competing interests and authors' conclusions: epidemiological study of ramdomised clinical trials published in the BMJ [J]. BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7358): : 249 - 252

[1] Angell M., 2004, TRUTH DRUG CO THEY D

[2] Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures [J]. BRITISH JOURNAL OF CANCER, 2005, 93 (05) : 504 - 509

[3] Chalmers L, 2004, NEW SCI, V181, P19

[4] Postmarketing surveillance - Lack of vigilance, lack of trust [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21): : 2647 - 2650

[5] How can research ethics committees protect patients better? [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7400): : 1199 - 1201

[6] Adjusting Europe's drug regulation to public health needs [J]. LANCET, 2001, 358 (9275) : 64 - 67

[7] Godlee F, 2006, BMJ-BRIT MED J, V2006, P333

[8] COX-2 inhibitors, other NSAIDs, and cardiovascular risk - The seduction of common sense [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (13): : 1653 - 1656

[9] Open access to industry's clinically relevant data - Urgently needed, but when will we get it, and in what form? [J]. BRITISH MEDICAL JOURNAL, 2004, 329 (7457): : 64 - 65

[10] Association between competing interests and authors' conclusions: epidemiological study of ramdomised clinical trials published in the BMJ [J]. BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7358): : 249 - 252